» Articles » PMID: 36701340

Renal Function is Associated with One-month and One-year Mortality in Patients with Intracerebral Hemorrhage

Overview
Journal PLoS One
Date 2023 Jan 26
PMID 36701340
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study evaluated short-term (1-month) and long-term (1-year) mortality risks associated with the glomerular filtration rate (eGFR) on admission for patients with intracerebral hemorrhage.

Methods: From the Taiwan Stroke Registry data from April 2006 to December 2016, we identified and stratified patients with intracerebral hemorrhage into five subgroups by the eGFR level on admission: ≥90, 60-89, 30-59, 15-29, and <15 mL/min/1.73 m2 or on dialysis. Risks for 1-month and 1-year mortality after intracerebral hemorrhage were compared by the eGFR levels.

Results: Both the 1-month and 1-year mortality rates progressively increased with the decrease in eGFR levels. The 1-month mortality rate in patients with eGFR < 15 mL/min/1.73 m2 or on dialysis was approximately 5.5-fold greater than that in patients with eGFR ≥ 90 mL/min/1.73 m2 (8.31 versus 1.50 per 1000 person-days), with an adjusted hazard ratio (HR) of 4.59 [95% confidence interval (CI) = 2.71-7.78]. Similarly, the 1-year mortality in patients with eGFR < 15 mL/min/1.73 m2 or on dialysis was 7.5 times that in patients with eGFR ≥ 90 mL/min/1.73 m2 (2.34 versus 0.31 per 1000 person-days), with an adjusted HR of 4.54 (95% CI 2.95-6.98).

Conclusion: Impairment of renal function is an independent risk factor for mortality in patients with intracerebral hemorrhage in a gradual way. The eGFR level is a prognostic indicator for patients with intracerebral hemorrhage.

Citing Articles

Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: a nationwide, propensity score study.

Yu J, Li P, Chen D, Huang W, See L Sci Rep. 2024; 14(1):4771.

PMID: 38413742 PMC: 10899247. DOI: 10.1038/s41598-024-55500-z.


Intracerebral Hemorrhage in Renal Compromised State: How is the Combination?.

Chakraborty D Ann Indian Acad Neurol. 2023; 26(4):374-375.

PMID: 37970297 PMC: 10645200. DOI: 10.4103/aian.aian_612_23.


Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review.

Kourtidou C, Tziomalos K Biomedicines. 2023; 11(9).

PMID: 37760839 PMC: 10525494. DOI: 10.3390/biomedicines11092398.

References
1.
Hao Z, Wu B, Lin S, Kong F, Tao W, Wang D . Association between renal function and clinical outcome in patients with acute stroke. Eur Neurol. 2010; 63(4):237-42. DOI: 10.1159/000285165. View

2.
Hsieh F, Lien L, Chen S, Bai C, Sun M, Tseng H . Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan. Circulation. 2010; 122(11):1116-23. DOI: 10.1161/CIRCULATIONAHA.110.936526. View

3.
Herzog C, Asinger R, Berger A, Charytan D, Diez J, Hart R . Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011; 80(6):572-86. DOI: 10.1038/ki.2011.223. View

4.
Gonzalez-Perez A, Gaist D, Wallander M, McFeat G, Garcia-Rodriguez L . Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network). Neurology. 2013; 81(6):559-65. DOI: 10.1212/WNL.0b013e31829e6eff. View

5.
Su G, Iwagami M, Qin X, McDonald H, Liu X, Carrero J . Kidney disease and mortality in patients with respiratory tract infections: a systematic review and meta-analysis. Clin Kidney J. 2021; 14(2):602-611. PMC: 7886553. DOI: 10.1093/ckj/sfz188. View